Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Melletus”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableActive Not RecruitingNCT07180251
What this trial is testing

Impact of Glycemic Variability on People With Gastrointestinal Cancer and Diabetes After Surgery

Who this might be right for
Diabetes MelletusGastrointestinal Cancers
National Taiwan University Hospital 260
Not applicableNot Yet RecruitingNCT07257068
What this trial is testing

Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

Who this might be right for
Checkpoint InhibitorPilot StudyDiabetes Melletus
M.D. Anderson Cancer Center 14
Not applicableUnknownNCT02438943
What this trial is testing

An Intervention to Improve Management of Dyslipidemia in Primary Care

Who this might be right for
Cardiovascular DiseaseDyslipidemiaDiabetes Melletus+1 more
The University of The West Indies 500
Not applicableLooking for participantsNCT07518004
What this trial is testing

ROME GS System Study

Who this might be right for
DiabetesDiabetes Melletus, Type 1Diabetes Mellitus, Type 2
Senseonics, Inc. 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07613307
What this trial is testing

Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

Who this might be right for
Diabetes Mellitus, Type 2Diabetes MelletusGlucose Metabolism Disorders+13 more
Eli Lilly and Company 130